Related Experiment Video
Updated: Mar 22, 2026
08:32
Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
1.4K
Chemoradiation Reprograms Tumor Cells and the Immune Microenvironment in Cervical Cancer
Tito A Sandoval1, Yize Li2,3, Naoshad Muhammad1
1Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri.
Cancer Research
|March 20, 2026
Summary
Researchers identified MDM2 as a target to overcome cervical cancer treatment resistance. Inhibiting MDM2 alongside chemoradiotherapy (CRT) improved responses in preclinical models, offering new hope for patients.
Area of Science:
- Oncology
- Immunology
- Genetics
Background:
- Cervical cancer persists as a major global health concern, necessitating novel therapeutic strategies.
- Chemoradiotherapy (CRT) is a standard treatment, but resistance remains a significant clinical challenge.
- Understanding the tumor microenvironment's response to CRT is crucial for improving outcomes.
Purpose of the Study:
- To define cellular and molecular changes in cervical tumors during CRT.
- To identify therapeutic targets that can overcome CRT resistance.
- To investigate the impact of CRT on tumor-immune cell interactions.
Main Methods:
- Integrated analysis of RNA sequencing and single-cell transcriptomics in human cervical tumors.
- Multicohort longitudinal study design.
- Preclinical models to test therapeutic interventions.
Main Results:
- Identified MDM2 as a key mediator of radiation response in tumor and immune cells.
- MDM2 inhibition enhanced radiotherapy effects in HPV-positive, TP53 wild-type cervical cancer models.
- Combined MDM2 inhibition and CRT reshaped the immune landscape and improved radiation response.
Conclusions:
- MDM2 inhibition represents a promising strategy to overcome CRT resistance in cervical cancer.
- Targeting MDM2 could enhance treatment efficacy and improve patient outcomes.
- Insights into therapy-induced changes can guide future treatment strategies for resistant HPV-positive cancers.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:17The Tumor Microenvironment
8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
02:49Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K